Core Insights - Shengmei Shanghai reported a revenue of 5.146 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 29.42% [1] - The net profit attributable to the parent company reached 1.266 billion yuan, showing a significant increase of 66.99% year-on-year [1] - Research and development investment totaled 868 million yuan, accounting for 16.87% of the revenue, with a year-on-year increase of 41.89% [1] Financial Performance - Revenue for the first three quarters: 5.146 billion yuan, up 29.42% year-on-year [1] - Net profit: 1.266 billion yuan, up 66.99% year-on-year [1] - R&D investment: 868 million yuan, 16.87% of revenue, up 41.89% year-on-year [1] Order Backlog - Total order backlog as of September 29: 9.072 billion yuan, an increase of 34.10% compared to the same period last year [1] Production Capacity - The company has two production plants in the Lingang factory area, with Plant A already in operation and capable of reaching a production capacity of 10 billion yuan [1] - The current production capacity supports the company's annual performance guidance target of 6.5 billion to 7.1 billion yuan for this year [1] - Plant B is expected to begin renovations next year, with production anticipated to start in the second half of the year [1]

Core Insights - The company, Shengmei Shanghai, reported strong financial performance for the first three quarters of 2025, with revenue reaching 5.146 billion yuan, a year-on-year increase of 29.42%, and net profit attributable to shareholders of 1.266 billion yuan, up 66.99% [1] - The company continues to implement its development strategy focused on "technological differentiation, product platformization, and global customer base," which has led to improved product technology and market recognition [1][5] Financial Performance - For the first three quarters of 2025, Shengmei Shanghai achieved a revenue of 5.146 billion yuan, representing a 29.42% year-on-year growth [1] - The net profit attributable to shareholders was 1.266 billion yuan, reflecting a 66.99% increase compared to the previous year [1] - The non-recurring net profit was 1.107 billion yuan, showing a growth of 49.48% year-on-year [1] Product Development and Innovation - The company has launched several innovative products, including the upgraded Ultra C wb wet cleaning equipment and the first Ultra Lith KrF and Ultra ECDP electrochemical plating equipment, enhancing its market offerings [2] - Shengmei Shanghai's cleaning equipment covers 95% of process applications, and its plating equipment achieves full technical coverage, showcasing its competitive edge in the semiconductor equipment market [2] Research and Development - Research and development investment for the first nine months of 2025 reached 868 million yuan, a 41.89% increase year-on-year, accounting for 16.87% of revenue [4] - The company holds 494 patents, with 489 being invention patents, which supports its continuous innovation and provides legal protection for its technologies [4] - The company was awarded the "Integrated Circuit Innovation Achievement Award" at the 2025 China International Industry Fair for its Ultra C Tahoe cleaning equipment, highlighting its technological advancements [4] Market Strategy - The chairman of Shengmei Shanghai indicated that the company aims to capture 50% to 60% of the market share for its main products, cleaning and plating equipment, while also expanding its platform products [3] - The company plans to maintain its strategic focus on "technological differentiation, product platformization, and global customer base" to drive high-quality growth and support industry development [5]

Group 1 - The Shanghai Composite Index rose by 0.70% to close at 4016.33 points, while the Shenzhen Component Index increased by 1.95% to 13691.38 points, and the ChiNext Index surged by 2.93% to 3324.27 points [1] - The overnight performance of major U.S. indices showed the Dow Jones Industrial Average decreased by 0.16%, the Nasdaq Composite rose by 0.55%, and the S&P 500 remained unchanged [1] - The Philadelphia Semiconductor Index increased by 1.85%, with notable movements in semiconductor stocks such as NXP Semiconductors down by 3.87% and Micron Technology up by 2.13% [1] Group 2 - Zhongwei Company reported a revenue of 8.063 billion yuan for the first three quarters of 2025, a year-on-year increase of approximately 46.40%, with net profit attributable to shareholders reaching 1.211 billion yuan, up 32.66% [2] - Shengmei Shanghai achieved a revenue of 1.881 billion yuan in Q3 2025, reflecting a year-on-year growth of 19.61%, and a net profit of 570 million yuan, which is an increase of 81.04% [2] - A strategic emerging industry development fund initiated by the State-owned Assets Supervision and Administration Commission has been launched in Beijing with an initial scale of 51 billion yuan, aimed at accelerating the development of strategic emerging industries [2] Group 3 - The development of multimodal large models is expected to further drive demand for computing power, with domestic internet companies increasing their investments in AI [3] - Domestic storage manufacturers are projected to contribute significantly to the capital expenditure of domestic wafer fabs next year, with AI development likely to boost the storage chip industry cycle [3] - The semiconductor equipment and materials industry is identified as a key area for domestic substitution, benefiting from the expansion of semiconductor demand driven by the AI revolution and advancements in lithography technology [3]

Group 1: Guizhou Moutai - Guizhou Moutai reported a net profit of 646.27 billion yuan for the first three quarters of 2025, an increase of 6.25% year-on-year [1][2] - The company's revenue for the first three quarters reached 1,284.54 billion yuan, reflecting a growth of 6.36% compared to the previous year [1][2] Group 2: Midea Group - Midea Group achieved a net profit of 378.83 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 19.51% [3][4] - The company's revenue for the same period was 3,630.57 billion yuan, up 13.82% year-on-year [3][4] Group 3: Mindray Medical - Mindray Medical reported a net profit of 75.7 billion yuan for the first three quarters of 2025, a decline of 28.83% year-on-year [5][6] - The company's revenue for the first three quarters was 258.34 billion yuan, down 12.38% compared to the previous year [5][6] Group 4: SanHuan Group - SanHuan Group's net profit for the first three quarters of 2025 was 19.59 billion yuan, reflecting a growth of 22.16% year-on-year [7][8] - The company's revenue for the same period reached 65.08 billion yuan, an increase of 20.96% year-on-year [7][8] Group 5: Longyuan Power - Longyuan Power reported a net profit of 43.93 billion yuan for the first three quarters of 2025, a decrease of 21.02% year-on-year [9][10] - The company's revenue for the same period was 222.21 billion yuan, down 17.29% compared to the previous year [9][10] Group 6: China Nuclear Power - China Nuclear Power's net profit for the first three quarters of 2025 was 80.02 billion yuan, a decline of 10.42% year-on-year [12][13] - The company's revenue for the same period reached 616.35 billion yuan, an increase of 8.16% year-on-year [12][13] Group 7: Fenjie Media - Fenjie Media reported a net profit of 42.40 billion yuan for the first three quarters of 2025, an increase of 6.87% year-on-year [14][15] - The company's revenue for the same period was 96.07 billion yuan, reflecting a growth of 3.73% year-on-year [14][15] Group 8: Tianfu Communication - Tianfu Communication achieved a net profit of 14.65 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 50.07% [17][18] - The company's revenue for the same period was 39.18 billion yuan, up 63.63% year-on-year [17][18] Group 9: Lingyi Technology - Lingyi Technology reported a net profit of 19.41 billion yuan for the first three quarters of 2025, reflecting a growth of 37.66% year-on-year [19][20] - The company's revenue for the same period reached 375.90 billion yuan, an increase of 19.25% year-on-year [19][20] Group 10: Rongsheng Petrochemical - Rongsheng Petrochemical's net profit for the first three quarters of 2025 was 8.88 billion yuan, a growth of 1.34% year-on-year [21] - The company's revenue for the same period was 2,278.15 billion yuan, down 7.09% compared to the previous year [21] Group 11: ShenNan Circuit - ShenNan Circuit reported a net profit of 23.26 billion yuan for the first three quarters of 2025, an increase of 56.30% year-on-year [22] - The company's revenue for the same period was 167.54 billion yuan, reflecting a growth of 28.39% year-on-year [22] Group 12: Jiangbolong - Jiangbolong achieved a net profit of 7.13 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 27.95% [23] - The company's revenue for the same period reached 167.34 billion yuan, up 26.12% year-on-year [23] Group 13: New Yisheng - New Yisheng reported a net profit of 63.27 billion yuan for the first three quarters of 2025, reflecting a growth of 284.37% year-on-year [24] - The company's revenue for the same period was 165.05 billion yuan, an increase of 221.70% year-on-year [24] Group 14: China Merchants Bank - China Merchants Bank achieved a net profit of 1,137.72 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 0.52% [25] - The company's revenue for the same period was 2,514.2 billion yuan, down 0.51% compared to the previous year [25] Group 15: Zhongwei Company - Zhongwei Company reported a net profit of 12.11 billion yuan for the first three quarters of 2025, a growth of approximately 32.66% year-on-year [26] - The company's revenue for the same period reached 80.63 billion yuan, an increase of approximately 46.40% year-on-year [26] Group 16: Microchip Biotech - Microchip Biotech's non-public offering was approved, aiming to raise up to 9.5 billion yuan for innovative drug research and development [27] Group 17: Longyuan Power's Fundraising - Longyuan Power plans to raise up to 50 billion yuan through a private placement to invest in renewable energy projects [28] Group 18: North University Pharmaceutical - North University Pharmaceutical's chairman was detained for investigation, but the company's operations remain normal [29] Group 19: Deyang Shares - Deyang Shares reported a net profit of 23.47 billion yuan for the first three quarters of 2025, a growth of 4.79% year-on-year [30] Group 20: Xiechuang Data - Xiechuang Data achieved a net profit of 6.98 billion yuan for the first three quarters of 2025, marking a year-on-year increase of 25.30% [31] Group 21: Zhifei Biological - Zhifei Biological reported a net loss of 12.06 billion yuan for the first three quarters of 2025, primarily due to lower sales and increased provisions [32] Group 22: Softcom Power - Softcom Power achieved a net profit of 9.89 billion yuan for the first three quarters of 2025, reflecting a growth of 30.21% year-on-year [33] Group 23: Magmi Technology - Magmi Technology reported a net profit of 2.13 billion yuan for the first three quarters of 2025, a decline of 48.29% year-on-year [34] Group 24: Huali Group - Huali Group's net profit for the first three quarters of 2025 was 24.35 billion yuan, a decrease of 14.34% year-on-year [35]

Core Viewpoint - Shengmei Shanghai (688082.SH) reported strong financial performance for the first three quarters of 2025, indicating significant growth in both revenue and net profit [1] Financial Performance - The company achieved total operating revenue of 5.146 billion yuan, representing a year-on-year increase of 29.42% [1] - The net profit attributable to shareholders reached 1.266 billion yuan, showing a year-on-year growth of 66.99% [1] - Basic earnings per share were reported at 2.87 yuan [1]

Core Insights - The company reported a revenue of 5.146 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 29.42% [1] - The net profit attributable to shareholders reached 1.266 billion yuan, with a year-on-year increase of 66.99% [1] - The basic earnings per share stood at 2.87 yuan [2] Financial Performance - The company achieved a gross margin of 49.54%, up by 1.07 percentage points year-on-year, and a net margin of 24.59%, which increased by 5.53 percentage points compared to the same period last year [2] - In Q3 2025, the gross margin was 47.48%, showing a year-on-year increase of 0.39 percentage points but a quarter-on-quarter decrease of 3.15 percentage points [2] - The net margin for Q3 was 30.30%, up by 10.27 percentage points year-on-year and 7.36 percentage points quarter-on-quarter [2] Expense Analysis - Total operating expenses for the period were 1.317 billion yuan, an increase of 227 million yuan year-on-year, with an expense ratio of 25.60%, down by 1.82 percentage points from the previous year [2] - Sales expenses grew by 34.51% year-on-year, while management expenses decreased by 7.82% [2] - R&D expenses increased by 27.59%, and financial expenses saw a significant reduction of 136.54% [2] Company Overview - The company, established on May 17, 2005, is located in the China (Shanghai) Free Trade Zone and specializes in the R&D, production, and sales of semiconductor equipment [3] - The main revenue source is from product sales, accounting for 99.72%, with service provision making up 0.28% [3] - The company is classified under the electronic-semiconductor-semiconductor equipment industry and is associated with concepts such as advanced packaging and integrated circuits [3]

国泰海通证券股份有限公司 关于盛美半导体设备（上海）股份有限公司 调整募集资金投资项目拟投入募集资金金额的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 盛美半导体设备（上海）股份有限公司（以下简称"盛美上海"、"公司"或"发 行人"）首次公开发行股票并在科创板上市以及2024年度向特定对象发行股票的 持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第1号——规范运作》等有关规定，对公司调整募集资金投 资项目拟投入募集资金金额的事项进行了核查，具体情况如下： 一、募集资金的基本情况 根据中国证券监督管理委员会核发的《关于同意盛美半导体设备（上海）股 份有限公司向特定对象发行股票注册的批复》（证监许可[2025]1338号），公司于 2025年9月26日向特定对象发行A股38,601,326股（以下简称"本次发行"），每股 的发行价为人民币116.11元，募集资金总额为人民币4,481,999,961.86元，扣除各 项发行费用人民币46,984,264.81元（不含 ...

为规范公司及子公司募集资金的管理、存放和使用，切实保护投资者权益， 公司及子公司盛帷半导体设备（上海）有限公司开设了募集资金专项账户，并与 保荐机构、存放募集资金的各商业银行签署了《募集资金专户存储三方监管协议》 《募集资金专户存储四方监管协议》。募集资金到账后，已全部存放于经公司董 事会批准开设的募集资金专项账户内。 并以募集资金置换的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 盛美半导体设备（上海）股份有限公司（以下简称"盛美上海"、"公司"或"发 行人"）首次公开发行股票并在科创板上市以及2024年度向特定对象发行股票的 持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第1号——规范运作》等有关规定，对公司使用自有资金方 式支付募投项目所需资金并以募集资金置换的事项进行了核查，具体情况如下： 一、募集资金的基本情况 国泰海通证券股份有限公司 关于盛美半导体设备（上海）股份有限公司 使用自有资金方式支付募投项目所需资金 根据中国证券监督管理委员会核发的《关于 ...

国泰海通证券股份有限公司 关于盛美半导体设备（上海）股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 盛美半导体设备（上海）股份有限公司（以下简称"盛美上海"、"公司"或"发 行人"）首次公开发行股票并在科创板上市以及2024年度向特定对象发行股票的 持续督导保荐机构，根据《证券发行上市保荐业务管理办法》《上市公司募集资 金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上 市公司自律监管指引第1号——规范运作》等有关规定，对公司使用部分闲置募 集资金进行现金管理的事项进行了核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会核发的《关于同意盛美半导体设备（上海）股 份有限公司向特定对象发行股票注册的批复》（证监许可[2025]1338号），公司于 2025年9月26日向特定对象发行A股38,601,326股（以下简称"本次发行"），每股 的发行价为人民币116.11元，募集资金总额为人民币4,481,999,961.86元，扣除各 项发行费用人民币46,984,264.81元（不含增值税），实际 ...

您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://ac.mof.gov.cn）"进行查询 盛美半导体设备(上海)股份有限公司 募集资金置换专项鉴证报告 信会师报字[2025]第 ZI10819 号 立信会计师事务所(特殊普通合伙) O CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS LLP 募集资金置换专项鉴证报告 信会师报字[2025]第 ZI10819 号 盛美半导体设备(上海)股份有限公司全体股东: 我们接受委托,对后附的盛美半导体设备(上海)股份有限公司 (以下简称"贵公司")编制的截至 2025年9月26 日止《关于以募 集资金置换预先投入募投项目及支付发行费用的自筹资金的专项说 明》(以下简称"专项说明")进行了合理保证的专项鉴证。 一、管理层的责任 贵公司管理层的责任是按照中国证券监督管理委员会《上市公司 募集资金监管规则》、《上海证券交易所科创板上市公司自律监管指引 第1号 -- 规范运作》的相关规定编制专项说明,这种 ...